Statistics

Total Visits

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)31

Select a period of time:

Number of views in the range

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)20

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20251
March 202518
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
Germany1
Spain1
 

Top cities views

Views